Showing results (51-60 of 72) with videos related to

Sort By:
Pageof 8
Medcomm|March 10, 2025
PD-1/PD-L1 Inhibitors Plus Chemotherapy Versus Chemotherapy Alone as First-Line Therapy for Patients With Unfavorable Cancer of Unknown Primary: A Multicenter, Retrospective Cohort StudyRiqing Huang, Haifeng Li, Shuo Li, et al.
BMC Cancer|September 30, 2024
Eribulin plus carboplatin combination for HER2-negative metastatic breast cancer: a multicenter, real-world cohort studyMengqian Ni, Lijia Zhou, Yongkui Lu, et al.
NPJ Breast Cancer|December 27, 2022
Phase I study of LZM005 in patients with HER2-positive metastatic breast cancerCong Xue, Haifeng Li, Herui Yao, et al.
Veterinary Research Communications|July 28, 2026
A novel Chaphamaparvovirus detected in breeding Muscovy Ducks with hepatitisYadong Gao, Jiawen Dong, Ouyang Peng, et al.
BMC Cancer|March 6, 2025
CYP2D6 polymorphisms and endoxifen concentration in Chinese patients with breast cancerCong Xue, Wei Yang, Anqi Hu, et al.
Cancer Communications (London, England)|April 23, 2026
Camrelizumab Plus Nab-paclitaxel in Patients with Previously Treated Advanced Urothelial Carcinoma: A Multicenter Phase II StudyHaifeng Li, Meiting Chen, Riqing Huang, et al.
Cancer Management and Research|December 3, 2021
Surgery and Chemotherapy versus Chemotherapy Only in Older Persons with Primary Intestinal Diffuse Large B-Cell LymphomaLimei Zhang, He Huang, Zhao Wang, et al.
BMC Cancer|October 19, 2023
Effect of chemotherapy alone or combined with immunotherapy for locally advanced or metastatic genitourinary small cell carcinoma: a real-world retrospective studyRiqing Huang, Meiting Chen, Haifeng Li, et al.
BJU International|November 27, 2023
Gemcitabine/nab-paclitaxel vs gemcitabine/carboplatin for advanced urothelial carcinomaXin An, Cong Xue, Meiting Chen, et al.
European Journal of Medicinal Chemistry|March 14, 2025
Rapid discovery of pseudorabies virus inhibitors repurposed from the antimicrobial agent ciprofloxacinLin Wei, Yun You, Yang Hu, et al.
Pageof 8